Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypertension in the elderly

L R LaPalio1

  • 1Department of Geriatrics, La Grange Memorial Hospital, IL 60525, USA.

American Family Physician
|September 15, 1995
PubMed
Summary

Systolic hypertension poses a greater cardiovascular risk than diastolic hypertension. Treating isolated systolic hypertension, even in older adults, significantly lowers cardiovascular event rates.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distinguishing Lewy body dementia.

Hospital practice (1995)·1998
Same author

An old mouth speaks out: a geriatrician's message to the dental profession.

Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry·1994
Same author

Withdrawal of tube feedings in Illinois: the burden of a court order.

Journal of the American Geriatrics Society·1990
Same author

Time study of students and house staff on a university medical service.

Journal of medical education·1981

Area of Science:

  • Cardiology
  • Geriatrics
  • Public Health

Background:

  • Systolic blood pressure (SBP) elevation is a critical cardiovascular disease (CVD) risk factor.
  • Isolated systolic hypertension (ISH) management is crucial, particularly in the elderly.

Purpose of the Study:

  • To evaluate the significance of systolic versus diastolic blood pressure in CVD risk.
  • To assess the impact of ISH treatment on cardiovascular outcomes.
  • To provide guidance on managing hypertension in various patient populations, including the elderly.

Main Methods:

  • Comparative analysis of SBP and diastolic blood pressure (DBP) as CVD risk factors.
  • Review of studies on the efficacy of ISH treatment in reducing fatal and nonfatal cardiovascular events.
  • Evaluation of treatment strategies, including non-pharmacologic measures, behavior modification, and pharmacotherapy.

Main Results:

  • SBP > 160 mm Hg is a more significant CVD risk factor than DBP > 95 mm Hg, irrespective of age.
  • ISH treatment demonstrably reduces cardiovascular events, including in patients over 80.
  • Non-pharmacologic interventions are recommended for 3-6 months for mild hypertension; medication may be needed sooner for high-risk individuals.
  • Initial medication doses for frail elderly should be halved.
  • Long-acting diuretics or beta-blockers are preferred first-line agents; ACE inhibitors and calcium channel blockers lack proven mortality benefits in uncomplicated hypertension but may help specific comorbidities.

Conclusions:

  • Systolic hypertension is a primary target for CVD prevention.
  • Effective management of ISH, including in advanced age, improves cardiovascular outcomes.
  • Treatment strategies should be individualized based on blood pressure levels, comorbidities, and patient frailty.

Related Experiment Videos